Impact of experimental haemodilution on platelet function, thrombin generation and clot firmness: Effects of different coagulation factor concentrates

Blood Transfusion

Volumn 11, Issue 3, 2013, Pages 391-399

  Caballo, Carolina ^a   Escolar, Gines ^a   Diaz Ricart, Maribel ^a   Lopez Viólchez, Irene ^a   Lozano, Miguel ^a   Cid, Joan ^a   Pino, Marcos ^a   Beltrán, Joan ^b   Basora, Misericordia ^b   Pereira, Arturo ^a   Galan, Ana M ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Coagulation factor concentrates; Haemodilution; Platelet function; Thrombin generation; Thromboelastometry

Indexed keywords

BLOOD CLOTTING FACTOR CONCENTRATE; FIBRINOGEN; GELAFUNDINA; GELATIN; HAEMOCOMPLETTAN; HETASTARCH; HUMAN ALBUMIN; LACRINGER; PLASMALYTE; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RINGER LACTATE SOLUTION; SODIUM CHLORIDE; THROMBIN; UNCLASSIFIED DRUG; BLOOD CLOTTING FACTOR; COLLOID; CRYSTALLOID; HETASTARCH DERIVATIVE; ISOTONIC SOLUTION;

ARTICLE; BLOOD CLOT; BLOOD CLOTTING; COLLOID; CRYOPRECIPITATE; CRYSTALLOID; HEMODILUTION; HUMAN; PLATELET REACTIVITY; THROMBOCYTE FUNCTION; CLINICAL TRIAL; DRUG EFFECTS; FEMALE; MALE; METABOLISM; PHARMACOLOGY; THROMBOCYTE; THROMBOCYTE ADHESION; THROMBOELASTOGRAPHY;

BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BLOOD PLATELETS; COLLOIDS; FEMALE; HEMODILUTION; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; ISOTONIC SOLUTIONS; MALE; PLATELET ADHESIVENESS; THROMBELASTOGRAPHY; THROMBIN;

EID: 84882412901     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2012.0034-12     Document Type: Article

References (35)

1. Hess JR. Blood and coagulation support in trauma care. Hematology Am Soc Hematol Educ Program 2007; 187-91.
2. Tieu BH, Holcomb JB, Schreiber MA. Coagulopathy: its pathophysiology and treatment in the injured patient. World J Surg 2007; 3C1: 1055-64.
3. Levi M, Ten CH. Disseminated intravascular coagulation. N Engl J Med 1999; 341: 586-92.
4. Bolliger D, Gorlinger K, Tanaka KA. Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology 2010; 113: 1205-19.
5. Fenger-Eriksen C, Tonnesen E, Ingerslev J, Sorensen B. Mechanisms of hydroxyethyl starch-induced dilutional coagulopathy. J Thromb Haemost 2009; 7: 1099-105.
6. Kozek-Langenecker S. Management of massive operative blood loss. Minerva Anestesiol 2007; 73: 401-15.
7. Rossaint R, Bouillon B, Cerny V, et al. Management of bleeding following major trauma: an updated European guideline. Crit Care 2010; 14: R52.
8. Stainsby D, MacLennan S, Hamilton PJ. Management of massive blood loss: a template guideline. Br J Anaesth 2000; 85: 487-91.
9. Ho AM, Dion PW, Cheng CA, et al. A mathematical model for fresh frozen plasma transfusion strategies during major trauma resuscitation with ongoing hemorrhage. Can J Surg 2005; 48: 470-8.
10. Chowdhury P, Saayman AG, Paulus U, et al. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004; 125: 69-73.
11. Kitchens CS. To bleed or not to bleed? Is that the question for the PTT? J Thromb Haemost 2005; 3: 2607-11.
12. Fenger-Eriksen C, Tonnesen E, Ingerslev J, Sorensen B. Recombinant factor VIIa and fibrinogen display additive effect during in vitro haemodilution with crystalloids. Acta Anaesthesiol Scand 2009; 53: 332-8.
13. Fries D, Haas T, Klingler A, et al. Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy - A porcine model. Br J Anaesth 2006; 97: 460-7.
14. Schochl H, Nienaber U, Hofer G, et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010; 14: R55.
15. Theusinger OM, Baulig W, Asmis LM, et al. In vitro factor XIII supplementation increases clot firmness in Rotation Thromboelastometry (ROTEM). Thromb Haemost 2010; 104: 385-91.
16. Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376: 23-32.
17. Shenkman B, Savion N, Dardik R, et al. Testing of platelet deposition on polystyrene surface under flow conditions by the cone and plate(let) analyzer: role of platelet activation, fibrinogen and von Willebrand factor. Thromb Res 2000; 99: 353-61.
18. Anderson L, Quasim I, Soutar R, et al. An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. Transfus Med 2006; 16: 31-9.
19. Blasi A, Beltran J, Pereira A, et al. An assessment of thromboelastometry to monitor blood coagulation and guide transfusion support in liver transplantation. Transfusion 2012; DOI 10.1111/j.1537-2995.2011.03526.x.
20. Hron G, Kollars M, Binder BR, et al. Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA 2006; 296: 397-402.
21. Varadi K, Turecek PL, Schwarz HP. Thrombin generation assay and other universal tests for monitoring haemophilia therapy. Haemophilia 2004; 10 (Suppl. 2): 17-21.
22. van Veen JJ, Spahn DR, Makris M. Routine preoperative coagulation tests: an outdated practice? Br J Anaesth 2011; 106: 1-3.
23. Fries D, Innerhofer P, Schobersberger W. Time for changing coagulation management in trauma-related massive bleeding. Curr Opin Anaesthesiol 2009; 22: 267-74.
24. Johansson PI, Stissing T, Bochsen L, Ostrowski SR. Thrombelastography and thromboelastometry in assessing coagulopathy in trauma. Scand J Trauma Resusc Emerg Med 2009; 17: 45.
25. Aarts PA, van den Broek SA, Prins GW, et al. Blood platelets are concentrated near the wall and red blood cells, in the center in flowing blood. Arteriosclerosis 1988; 8: 819-24.
26. Jordan A, David T, Homer-Vanniasinkam S, et al. The effects of margination and red cell augmented platelet diffusivity on platelet adhesion in complex flow. Biorheology 2004; 41: 641-53.
27. Escolar G, Garrido M, Mazzara R, et al. Experimental basis for the use of red cell transfusion in the management of anemicthrombocytopenic patients. Transfusion 1988; 28: 406-11.
28. Valeri CR, Cassidy G, Pivacek LE, et al. Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss. Transfusion 2001; 41: 977-83.
29. Fenger-Eriksen C, Jensen TM, Kristensen BS, et al. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J Thromb Haemost 2009; 7: 795-802.
30. Hedner U. Mechanism of action of factor VIIa in the treatment of coagulopathies. Semin Thromb Hemost 2006; 32 (Suppl. 1): 77-85.
31. George JN, Pickett EB, Heinz R. Platelet membrane microparticles in blood bank fresh frozen plasma and cryoprecipitate. Blood 1986; 68: 307-9.
32. Sorensen B, Bevan D. A critical evaluation of cryoprecipitate for replacement of fibrinogen. Br J Haematol 2010; 149: 834-43.
33. Davenport R, Khan S. Management of major trauma haemorrhage: treatment priorities and controversies. Br J Haematol 2011; 155: 537-48.
34. Mitterlechner T, Innerhofer P, Streif W, et al. Prothrombin complex concentrate and recombinant prothrombin alone or in combination with recombinant factor X and FVIIa in dilutional coagulopathy: a porcine model. J Thromb Haemost 2011; 9: 729-37.
35. O'Connell NM, Perry DJ, Hodgson AJ, et al. Recombinant FVIIa in the management of uncontrolled hemorrhage. Transfusion 2003; 43: 1711-6.